Eledon Pharmaceuticals, Inc. (ELDN): Operating Income
Older than the company's other figures. The latest Operating Income is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
-$43.00M
Year ended 2023-12-31
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | -$43.00M | n/m | 2024-03-28, From 2023-01-01 |
| 2022-12-31 | -$88.43M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$36.87M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$18.46M | n/m | 2022-03-24, From 2020-01-01 |
| 2019-12-31 | -$16.05M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$14.06M | n/m | 2020-03-17, From 2018-01-01 |
| 2017-12-31 | -$13.12M | n/m | 2019-03-28, From 2017-01-01 |
| 2016-12-31 | -$5.13M | n/m | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | -$45.26M | n/m | 2017-03-03, From 2015-01-01 |
| 2014-12-31 | -$23.46M | n/m | 2017-03-03, From 2014-01-01 |
| 2013-12-31 | -$15.75M | n/m | 2016-03-10, From 2013-01-01 |
| 2012-12-31 | -$9.65M | n/a | 2015-03-26, From 2012-01-01 |